Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumicell
Newton, Massachusetts, United Stateslumicell.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Lumicell’s LumiSystem™, which combines the LUMISIGHT™ optical imaging agent and the Lumicell Direct Visualization System™, received historic dual FDA approval in 2024. Clinical trials demonstrated 84% diagnostic accuracy in detecting residual breast cancer during lumpectomy surgery. The system enables real-time intraoperative visualization of remaining tumor tissue within the surgical cavity—improving complete resection rates and reducing repeat surgeries. In pivotal trials such as INSITE, LumiSystem improved outcomes by identifying additional disease missed by standard methods in about 10% of patients[7][4].
- Therapeutic areas
- Oncology
- Modalities
- DeviceOptical imaging agent (pegulicianine)Small molecule (pegulicianine is a small molecule imaging agent)
- Industry
- Medical Imaging
02
Partnerships
Academic collaborations with MIT/Koch Institute noted[5].Early adoption at major centers like Stanford University School of Medicine and MD Anderson Cancer Center highlighted as key clinical partners/adopters[4][7].
Beyond the preview
Go deeper on Lumicell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lumicell.